Tobira Therapeutics
(TBRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,431 | 6,178 | 30,770 | 14,846 | 9,317 |
| Inventories | N/A | N/A | N/A | N/A | 498 |
| Other current assets | 0 | 0 | 6,211 | 4,580 | 0 |
| TOTAL | $63,251 | $7,191 | $39,128 | $19,683 | $10,845 |
| Non-Current Assets | |||||
| PPE Net | 400 | 474 | 108 | 66 | 93 |
| Intangibles | 0 | 0 | 1,823 | 1,771 | 1,855 |
| Other Non-Current Assets | 1,818 | 681 | 4,694 | 283 | 1,762 |
| TOTAL | $2,218 | $1,155 | $6,625 | $2,120 | $3,710 |
| Total Assets | $65,469 | $8,346 | $45,753 | $21,803 | $14,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,000 | 2,571 | N/A |
| Accounts payable and accrued liabilities | 3,089 | 1,887 | 1,557 | 203 | 320 |
| Accrued Expenses | 4,263 | 6,503 | 5,524 | 786 | 1,650 |
| Other current liabilities | 48 | 57 | 19 | 0 | N/A |
| TOTAL | $7,423 | $38,238 | $9,100 | $3,560 | $3,256 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,074 | 14,789 | 2,452 | 1,929 | 4,714 |
| Other Non-Current Liabilities | 184 | 2,679 | 0 | 0 | 0 |
| TOTAL | $15,275 | $17,508 | $2,452 | $1,929 | $4,714 |
| Total Liabilities | $22,698 | $55,746 | $11,552 | $5,489 | $7,970 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,816 | 3,734 | 2,814 | 2,264 | N/A |
| Common Shares | 19 | 0 | 21 | 0 | 0 |
| Retained earnings | -163,377 | -113,760 | -144,979 | -110,540 | -97,478 |
| Other shareholders' equity | 0 | 61,982 | 0 | 122,050 | 99,897 |
| TOTAL | $42,771 | $-47,400 | $34,201 | $16,314 | $6,585 |
| Total Liabilities And Equity | $65,469 | $8,346 | $45,753 | $21,803 | $14,555 |